Fig. 12

The structures of new anti-malaria drugs. The drugs presented include novel and experimental compounds that have shown potential against Plasmodium infections, such as Imatinib, Rosiglitazone, Cipargamin, ZY19489, and Ferroquine, among others. These structures represent different classes of anti-malaria agents currently under investigation or development, encompassing a range of mechanisms of action aimed at combating malaria